IP Library Granted Patent US 9,895,064
Granted Patent B2
US 9,895,064 · App. 13/989,800 · Granted Feb 20, 2018

Device and method for determining a disease activity

Inventors: Wouter Harry Jacinth Rensen (Eindhoven, NL); Pieter Klaas De Bokx (Eindhoven, NL)
Assignee: Hemics B.V.
A61B5/0082A61B5/0075A61B5/4528A61B5/4842A61B5/022A61B5/0261A61B5/6825A61B5/6829
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,895,064
App. No.
13/989,800
Granted
Feb 20, 2018
Kind
B2
Abstract

A system and method to determine a disease activity as a single value by way of optical measurements in order to facilitate an analysis of a current disease status and a future course of disease, thus assisting a doctor's diagnosis or decision on a therapy. A blood perfusion is varied in an area of interest, the area of interest is irradiated with light of at least two wavelengths, an intensity of light reflected and/or transmitted by the area of interest is detected, features are derived from detected intensity curves of at least two predetermined wavelengths under at least two different perfusion conditions, and the disease activity is determined using these features.

Claims (38)

1. A system for determining a disease activity of arthritis with respect to an area of interest of a body, the system comprising:

a perfusion manipulator adapted to vary a blood perfusion in the area of interest, wherein the area of interest includes a joint;

an irradiation unit adapted to irradiate the area of interest with light; and

a detection unit adapted to detect intensities of light reflected and/or transmitted by the area of interest under at least two different perfusion conditions in the area of interest; and

a controller adapted to:

record an intensity curve of detected intensities of light over time;

derive features from the detected intensities of light by fitting at least a part of the intensity curve by a fit function having fit parameters and using at least some of the fit parameters as the features for determining the disease activity; and

determine the disease activity of arthritis as a single value or a scalar value based on the features by using a predetermined regression vector,

wherein the controller is adapted to derive the features from the detected intensities of at least one predetermined wavelength or at least two predetermined wavelengths;

wherein the controller is adapted to determine the disease activity using an inner product of the regression vector and a feature vector; and

wherein the feature vector comprises at least the features derived from the intensity curve of the predetermined wavelength or intensity curves of the at least two predetermined wavelengths.

2. The system of claim 1 , wherein the irradiation unit is adapted to irradiate the area of interest with light of at least one wavelength or at least two wavelengths.

3. The system of claim 2 , wherein the irradiation unit is adapted to sequentially irradiate the area of interest with the at least two predetermined wavelengths.

4. The system of claim 1 , wherein the detection unit is adapted to differentiate between different wavelengths.

5. The system of claim 1 , wherein the perfusion manipulator is adapted to cyclically vary the blood perfusion in the area of interest.

6. The system of claim 1 , wherein said at least one predetermined wavelength or at least two predetermined wavelengths correspond to a wavelength or wavelengths that are determined to be the most significant wavelengths for determining the disease activity.

7. The system of claim 1 , wherein the wavelength or wavelengths include:

one wavelength of ca. 666±10 nm.

8. The system of claim 1 , wherein the features derived from the detected intensities of light include at least one of a maximum intensity, a minimum intensity, a drift, an intensity amplitude, a drop time, and an inflection point, or any combination thereof.

9. The system of claim 1 , wherein the detected intensities of light relate to optical measurements performed for more than one area of interest, and the controller is adapted to derive the features from the detected intensities of light for each area of interest.

10. The system of claim 1 , wherein the controller is adapted to:

determine at least one regression vector indicative for the disease activity by analyzing intensities measured for a plurality of patients having different levels of disease activity at a plurality of different wavelengths; and

select the at least two predetermined wavelengths corresponding to extrema in a spectrum of the regression vector.

11. The system of claim 1 , wherein the wavelength or wavelengths include two wavelengths of ca. 666±10 nm and 808±10 nm.

12. The system of claim 1 , wherein the wavelength or wavelengths include four wavelengths of ca. 666±10 nm, 808±10 nm, 835±10 nm, and 864±10 nm.

13. The system of claim 1 , wherein the wavelength or wavelengths include six wavelengths of ca. 586±10 nm, 638±10 nm, 666±10 nm, 808±10 nm, 835±10 nm, and 864±10 nm.

14. A method for determining a disease activity with respect to an area of interest in a body, the method comprising:

varying a blood perfusion in the area of interest wherein the area of interest includes a joint;

irradiating the area of interest with light; and

detecting intensities of light reflected and/or transmitted by the area of interest under at least two different perfusion conditions in the area of interest;

recording an intensity curve of detected intensities of light over time;

deriving features from the detected intensities of light by fitting at least a part of the intensity curve by a fit function having fit parameters and using at least some of the fit parameters as the features for determining the disease activity;

deriving the features from the detected intensities of at least one predetermined wavelength or at least two predetermined wavelengths; and

determining the disease activity of arthritis as a single value or a scalar value based on the features by using an inner product of a predetermined regression vector and a feature vector wherein the feature vector comprises at least the features derived from the intensity curve of the predetermined wavelength or intensity curves of the at least two predetermined wavelengths.

15. The method of claim 14 , wherein irradiating the area of interest with light comprises irradiating the area of interest with light of at least one wavelength or at least two wavelengths.

16. The method of claim 14 , wherein the wavelength or wavelengths include two wavelengths of ca. 666±10 nm and 808±10 nm.

17. The method of claim 14 , wherein the wavelength or wavelengths include four wavelengths of ca. 666±10 nm, 808±10 nm, 835±10 nm, and 864±10 nm.

18. The method of claim 14 , wherein the wavelength or wavelengths include six wavelengths of ca. 586±10 nm, 638±10 nm, 666±10 nm, 808±10 nm, 835±10 nm, and 864±10 nm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2020
From: HEMICS B.V.
To: DEMCON HEMICS B.V.
Reel/Frame 052931/0491 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2013
From: RENSEN, WOUTER HARRY JACINTH; KLAAS, PIETER
To: HEMICS, B.V.
Reel/Frame 030929/0667 →
Priority Claims (1)
EP 10192684 · Nov 26, 2010 · regional
Continuity (1)
Related Publication 20130310697A1 · Nov 21, 2013